Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Azenta (AZTA) Amortization of Deferred Charges (2022 - 2024)

Azenta's quarterly Amortization of Deferred Charges came in at -$1.4 million in Q1 2024, up 36.7% year-on-year from -$1.0 million in Q2 2023, and down 96.02% quarter-over-quarter from -$704000.0 in Q4 2023.

Azenta has reported Amortization of Deferred Charges for 3 years, with the latest figure at -$1.4 million in Q1 2024.

  • For the quarter ending Q1 2024, Amortization of Deferred Charges rose 36.7% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2024 stood at -$4.7 million (up 35.53% YoY), and the FY2023 full-year result was -$7.9 million, down 315.52% from the prior year.
  • Amortization of Deferred Charges for Q1 2024 stood at -$1.4 million, down from -$704000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $5.2 million in Q3 2022, with the low at -$7.1 million in Q2 2022.
  • Average Amortization of Deferred Charges over 3 years is -$1.5 million, with a median of -$1.5 million recorded in 2023.
  • Peak annual rise in Amortization of Deferred Charges reached 77.32% in 2023, while the deepest fall reached 118.01% in 2023.
  • Tracing AZTA's Amortization of Deferred Charges over 3 years: stood at -$3.1 million in 2022, then surged by 77.32% to -$704000.0 in 2023, then sank by 96.02% to -$1.4 million in 2024.
  • The last three Amortization of Deferred Charges figures came in at -$1.4 million (Q1 2024), -$704000.0 (Q4 2023), and -$928000.0 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Azenta 899.66 Mn 519.15 Mn 62.04 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 -1.38 Mn
Mar 31, 2024 -1.38 Mn
Dec 31, 2023 -704,000.00
Dec 31, 2023 -704,000.00
Sep 30, 2023 -928,000.00
Sep 30, 2023 -928,000.00
Jun 30, 2023 -1.66 Mn
Jun 30, 2023 -1.66 Mn
Mar 31, 2023 -2.18 Mn
Mar 31, 2023 -2.18 Mn
Dec 31, 2022 -3.10 Mn
Dec 31, 2022 -3.10 Mn
Sep 30, 2022 5.15 Mn
Sep 30, 2022 5.15 Mn
Jun 30, 2022 -7.11 Mn
Jun 30, 2022 -7.11 Mn